โจทย์ ปรนัย
What is the primary goal of the article according to its introduction?

The article’s introduction clearly states that its primary goal is to explore how generative AI can transform medical image synthesis by discussing technological advancements, medical applications, and related challenges. Therefore, it is not focused on economic impact, policy comparison, or model design, but rather on analyzing current progress and future directions in the field.

According to Khosravi et al. (2025, The Lancet Digital Health), the paper is written as a Viewpoint article — a type of scholarly work intended to summarize and analyze the state of a topic rather than conduct new experiments. In academic writing, the main purpose is typically stated in the introduction, often using verbs like explore, analyze, or discuss to clarify the article’s intent. S258975002500072X, Section “Generative vs. Discriminative Models”: Explains that generative AI models are capable of data creation, which is essential in medical imaging applications.

โจทย์ ปรนัย
How do generative AI models differ from traditional discriminative models in healthcare applications?

Generative AI models are designed to create new data instances that resemble real data — such as synthetic medical images — whereas traditional discriminative models are used mainly to classify, label, or interpret existing data. For example, a discriminative model can detect tumors in MRI scans, but a generative model can synthesize new MRI images for rare tumor cases to balance datasets.

In the article, Khosravi et al. (2025) explain that generative models like GANs, VAEs, and diffusion models can “synthesize realistic medical images” by learning data distributions, which differs fundamentally from discriminative models that focus on mapping inputs to specific categories. This concept aligns with machine learning theory, where: • Discriminative models estimate P(y|x) — the probability of a label given data. • Generative models estimate P(x, y) or P(x) — allowing them to generate new examples. S258975002500072X, Section 2.3: “Model as a dataset” facilitates secure collaboration by exchanging trained model parameters rather than raw clinical images.

โจทย์ ปรนัย
What is meant by the term “model as a dataset”?

The term “model as a dataset” refers to the concept of using a trained AI model — particularly its learned weights and parameters — as a representation of knowledge extracted from data, rather than sharing the original patient data itself. This approach enables institutions to collaborate and exchange insights across centers while maintaining data privacy, since no identifiable raw data leaves the local site. For example, hospitals can share their trained models to collectively improve diagnostic performance without exposing sensitive medical images.

In the article by Khosravi et al. (2025, The Lancet Digital Health), the authors describe “model as a dataset” as a strategy for privacy-preserving collaboration, where the model encapsulates statistical patterns learned from data. This idea aligns with principles of federated learning and privacy-preserving AI, which allow models to share learned information (weights or gradients) instead of exchanging real datasets. → Thus, the model effectively becomes a “dataset” in itself, containing compressed knowledge of the original data distribution without revealing patient information. S258975002500072X, Section 2.4: Physics-informed models embed physical or biological laws to improve interpretability and plausibility in medical imaging.

โจทย์ ปรนัย
Which statement correctly distinguishes physics-informed and statistical models?

Physics-informed models integrate known physical or biological laws — such as imaging physics, tissue properties, or acquisition parameters — into the AI learning process. By embedding these principles, they generate more realistic and consistent medical images that align with real-world biomedical constraints. In contrast, statistical or data-driven models rely purely on learning patterns from data distributions, without explicitly using physical equations or domain rules. Therefore, physics-informed models differ by combining data-driven learning with scientific priors derived from real-world physiology or imaging physics.

According to Khosravi et al. (2025, The Lancet Digital Health), physics-informed generative models use mathematical and biophysical constraints to “guide the synthesis process toward realistic and interpretable outcomes,” whereas statistical models such as GANs or diffusion models depend solely on the statistical properties of training data. This distinction follows the hybrid modeling principle, where integrating domain knowledge (physics or biology) improves accuracy and generalizability while reducing unrealistic artifacts.

โจทย์ ปรนัย
According to the article, what does the “image generation trilemma” describe?

The term “image generation trilemma” refers to the challenge of simultaneously achieving high image quality, broad diversity, and fast generation speed in medical image synthesis. In practice, improving one aspect often compromises another — for example, models that produce very realistic (high-quality) images usually require more computation time, while models optimized for speed may generate less diverse or less accurate results. This trade-off is a central technical limitation in developing generative models for clinical use, where both realism and efficiency are critical.

In Khosravi et al. (2025, The Lancet Digital Health), the authors explicitly describe the “image generation trilemma” as a constraint in current generative AI systems, emphasizing that it is difficult to achieve all three goals — diversity, fidelity (quality), and efficiency (speed) — simultaneously. This concept aligns with the computational trade-off principle in machine learning, which states that optimizing multiple performance metrics at once (e.g., accuracy vs. efficiency) often leads to compromises in at least one dimension.

โจทย์ ปรนัย
What is the Human Turing Test used for in medical image synthesis?

The Human Turing Test in medical image synthesis is used to evaluate how realistic AI-generated medical images appear compared to real ones. In this evaluation, expert radiologists or clinicians are asked to distinguish between real and synthetic images. If experts cannot reliably tell them apart, the generative model is considered to have achieved high realism or fidelity. This method helps assess perceptual quality beyond mathematical similarity measures (such as SSIM or FID), focusing instead on human-level visual judgment crucial for determining clinical usability.

According to Khosravi et al. (2025, The Lancet Digital Health), the Human Turing Test acts as a subjective validation tool to assess whether synthetic images can “fool” human experts, reflecting a benchmark similar to Alan Turing’s original concept in artificial intelligence (Turing, 1950). It aligns with the principle of perceptual realism, which emphasizes that in medical imaging, human experts’ ability to interpret or trust synthetic data depends on its perceptual authenticity.

โจทย์ ปรนัย
Which of the following is NOT mentioned as a potential benefit of synthetic data in healthcare?

The article mentions several benefits of using synthetic data in healthcare and medical imaging, such as: • Enhancing data diversity (increasing coverage, especially for rare patient groups), • Preserving patient privacy (reducing risks associated with personal data), • Facilitating multi-centre collaborations (allowing multiple institutions to share data without violating ethical guidelines), and • Supporting medical education and model training (enabling training for medical students and clinicians without relying solely on real patient data). However, the article does not state that synthetic data can “eliminate all medical biases permanently”. In reality, AI models may still contain biases if the training data itself is biased or if the synthetic data generation process does not sufficiently account for diversity. Therefore, this option is incorrect and is not mentioned in the article.

According to Khosravi et al. (2025, The Lancet Digital Health), synthetic data can mitigate but not completely remove biases. The authors emphasize that while generative AI enables privacy-preserving data sharing and improved diversity, bias may persist due to structural or systemic issues in the source datasets. This aligns with the AI fairness principle, which recognizes that model bias is not only a data issue but also depends on how models are trained and validated.

โจทย์ ปรนัย
What is one major ethical concern associated with generative AI in medical imaging?

A key ethical concern with generative AI in medical imaging is that the model might memorize and reproduce real patient data during image synthesis. If synthetic images closely resemble original patient images, there is a risk of patient reidentification, potentially violating privacy regulations. This concern is particularly critical when sharing synthetic data for research or multi-centre collaborations, as it may inadvertently expose sensitive information even though the images are labeled “synthetic.”

According to Khosravi et al. (2025, The Lancet Digital Health), generative models can unintentionally replicate rare features from training datasets, which can lead to data leakage and privacy breaches. This aligns with general principles of privacy-preserving AI, which emphasize minimizing the risk of revealing identifiable information while still enabling model training and data sharing.

โจทย์ ปรนัย
What regulatory precedent did the article cite for synthetic data technologies?

The article mentions that synthetic medical images, such as MRI scans generated by AI, have received regulatory clearance from the U.S. FDA when used as medical image-processing software. This serves as a precedent demonstrating that synthetic data technologies can meet safety and performance standards required for clinical use. It highlights that regulatory bodies are beginning to recognize and provide pathways for synthetic data in medical imaging, ensuring that these tools can be deployed responsibly in healthcare while maintaining quality and patient safety.

According to Khosravi et al. (2025, The Lancet Digital Health), the FDA’s clearance of synthetic MRI illustrates a regulatory milestone, showing that generative AI outputs can be formally assessed and approved as software as a medical device (SaMD). This aligns with broader principles of regulatory science, where innovative AI technologies must demonstrate accuracy, reliability, and clinical safety before adoption in healthcare.

โจทย์ ปรนัย
What is the main purpose of the article?

The article’s main goal is to assess how well different atherosclerotic cardiovascular disease (ASCVD) risk prediction models perform in East Asian populations. It compares existing models originally developed in Western populations with their applicability, accuracy, and calibration in East Asia. The study emphasizes the need for population-specific evaluation because cardiovascular risk factors and incidence rates can differ across regions, which affects the reliability of risk prediction tools.

According to the article (Author et al., Year), the authors highlight that most ASCVD risk models are derived from Western cohorts, and applying them directly to East Asian populations may lead to misestimation of risk. This aligns with the principle of external validation in clinical epidemiology, which states that predictive models should be validated in the specific population where they are intended to be used, to ensure accuracy and clinical utility.

โจทย์ ปรนัย
Which of the following models was originally developed for a Western population?

The Framingham Risk Score was developed based on data from the Framingham Heart Study in the United States, a predominantly Western population. It is widely used globally to predict ASCVD risk but may overestimate or underestimate risk when applied directly to East Asian populations due to differences in baseline risk factors, prevalence, and lifestyle. In contrast, models like China-PAR, Suita Score, KRPM, and NIPPON Data80 were specifically derived from East Asian cohorts and calibrated for local populations.

According to the article (Author et al., Year), the Framingham Risk Score’s applicability in East Asia requires external validation and recalibration. This aligns with the principle of population-specific model validation in clinical epidemiology, which states that predictive models should be validated in the population where they are intended to be applied to ensure accuracy and reduce misestimation.

โจทย์ ปรนัย
Why might Western-based risk prediction models overestimate ASCVD risk in East Asian populations?

Western-based risk prediction models, such as the Framingham Risk Score, were developed using populations with higher baseline rates of ASCVD. When these models are applied directly to East Asian populations, where baseline incidence of cardiovascular events is generally lower, the predicted risk tends to be overestimated. This is due to differences in genetics, lifestyle, diet, and other environmental factors that affect cardiovascular disease prevalence. Hence, population-specific calibration is necessary to improve prediction accuracy.

According to the article (Author et al., Year), applying Western models without adjustment can lead to systematic overestimation in East Asian cohorts. This aligns with the principle of external validation in clinical epidemiology, which emphasizes that predictive models must be tested and recalibrated in the target population to account for differences in baseline risk and demographic factors.

โจทย์ ปรนัย
What is the key advantage of the China-PAR model compared to Western-based models?

The China-PAR (Prediction for ASCVD Risk in China) model was developed and calibrated using large-scale, nationally representative data from multiple regions of China. This allows the model to capture regional variations in demographics, lifestyle, and baseline cardiovascular risk, making it more accurate and applicable to the East Asian population compared to Western-based models, which may overestimate risk due to differences in baseline incidence.

According to the article (Author et al., Year), China-PAR’s strength lies in its population-specific calibration, which follows the principle of external validation and model adaptation in clinical epidemiology. By reflecting local epidemiology, the model improves predictive performance and clinical utility in the target population.

โจทย์ ปรนัย
Which of the following variables is not typically included in ASCVD risk prediction models discussed in the article?

Most traditional ASCVD risk prediction models, including Framingham Risk Score, China-PAR, Suita Score, and KRPM, rely on clinical and lifestyle variables, such as: • Age • Blood pressure • Serum cholesterol • Smoking status These models do not typically include genetic ancestry markers as a predictor. While genetic factors may influence cardiovascular risk, they are not commonly incorporated into the models discussed in the article.

According to the article (Author et al., Year), conventional ASCVD models focus on modifiable and easily measurable risk factors to maximize clinical utility and ease of implementation. This aligns with the principle in clinical epidemiology that risk prediction models prioritize variables that are reliably measured and widely available, rather than complex genetic markers that require specialized testing.

โจทย์ ปรนัย
What is a major difference between the Suita Score and the Framingham Risk Score?

The Suita Score was specifically developed using epidemiological data from a Japanese cohort, making it population-specific. In contrast, the Framingham Risk Score was developed from a Western (U.S.) population. Using local data allows the Suita Score to more accurately estimate ASCVD risk in the Japanese population, reflecting differences in baseline incidence, lifestyle, and other regional factors. This highlights the importance of population-specific calibration when applying risk prediction models across different ethnic or regional populations.

According to the article (Author et al., Year), the Suita Score incorporates national or regional cardiovascular data to improve predictive accuracy for Japanese adults. This follows the principle of external validation and population-specific model development, ensuring that the model aligns with the epidemiological characteristics of the target population rather than relying on data from foreign cohorts.

โจทย์ ปรนัย
According to the article, what is a potential benefit of developing East Asia–specific risk models?

Western-based risk models, such as the Framingham Risk Score, often overestimate ASCVD risk in East Asian populations due to lower baseline incidence and regional differences in lifestyle and genetics. Developing East Asia–specific models (e.g., China-PAR, Suita Score, KRPM) allows for calibration to local epidemiological data, which improves the accuracy of predicted risk and reduces systematic overestimation. This ensures that clinicians can make better-informed decisions for preventive care and risk management tailored to the population.

According to the article (Author et al., Year), population-specific calibration is essential for external validity in predictive modeling. The principle of epidemiological relevance states that predictive models should be validated or recalibrated for the population in which they are applied, to ensure both reliability and clinical utility.

โจทย์ ปรนัย
Which factor was highlighted as influencing ASCVD risk differences among East Asian countries?

The article emphasizes that differences in diet, lifestyle, and cultural habits—for example, high salt consumption, physical activity patterns, and smoking prevalence—contribute significantly to variations in ASCVD risk among East Asian populations. These environmental and behavioral factors can modify baseline cardiovascular risk, making population-specific models essential for accurate prediction. Other factors, such as genetics, play a role, but the article highlights modifiable lifestyle and cultural differences as primary drivers of inter-country variation.

According to the article (Author et al., Year), epidemiological studies in East Asia show that regional differences in diet and lifestyle are major determinants of cardiovascular risk. This aligns with the principle of population heterogeneity in clinical epidemiology, which states that risk prediction must account for both environmental and behavioral factors to accurately reflect disease incidence.

โจทย์ ปรนัย
What future direction does the article suggest for improving ASCVD risk prediction?

The article suggests that future improvements in ASCVD risk prediction may involve combining multimodal data—such as clinical measurements, imaging biomarkers, lifestyle factors, and genomics—into AI-based predictive models. By integrating region-specific epidemiological data, these models can achieve higher accuracy and better personalization, addressing limitations of traditional models that rely on a limited set of variables or are calibrated for other populations. This approach allows predictive tools to account for heterogeneity in risk factors and improve clinical decision-making for East Asian populations.

According to the article (Author et al., Year), multimodal AI frameworks can process complex, diverse datasets and adapt predictions to local population characteristics. This aligns with the principle of precision medicine and data-driven risk prediction, where AI integrates multiple types of input data to optimize individual risk assessment, while still respecting population-level calibration.

โจทย์ ปรนัย
Which statement best explains the key difference in how VAEs, GANs, and DDPMs generate medical images according to the figure?

VAEs (Variational Autoencoders) generate images using an encoder–decoder architecture, learning a latent representation and reconstructing images probabilistically. GANs (Generative Adversarial Networks) rely on a generator–discriminator setup, where the generator creates images and the discriminator provides adversarial feedback to improve realism. DDPMs (Denoising Diffusion Probabilistic Models) work differently: they start with random noise and iteratively denoise through a reverse diffusion process to generate high-quality images, without using an encoder–decoder or discriminator structure. This is the key distinction highlighted in the figure: DDPMs achieve image generation through iterative denoising, whereas VAEs and GANs use fundamentally different architectures.

According to Khosravi et al. (2025, The Lancet Digital Health), DDPMs provide high-fidelity and diverse medical images by learning a noise-to-image mapping in a stepwise manner, which contrasts with VAE’s probabilistic reconstruction and GAN’s adversarial training. This aligns with the principle of model-specific generative mechanisms, emphasizing that understanding architecture differences is critical for selecting the appropriate model for medical image synthesis.

โจทย์ ปรนัย
Which of the following best explains the trend shown in Figure comparing age-standardized and crude CVD mortality rates among East Asian countries?

Japan has an older population, which would normally increase crude mortality rates. However, the figure shows that Japan maintains low CVD mortality rates even after age-standardization, indicating that its healthcare system, preventive strategies, and public health interventions effectively reduce cardiovascular deaths. This demonstrates that low mortality is not solely due to age structure, but also reflects health system performance and population-level disease prevention. In contrast, other countries’ differences between crude and age-standardized rates often reflect the impact of age distribution alone, but Japan’s low rates in both metrics highlight successful risk reduction strategies.

According to the article (Author et al., Year), age-standardized mortality provides a population-independent measure of disease burden. Japan’s low rates in both crude and age-standardized metrics illustrate the combined effect of healthcare quality, preventive measures, and lifestyle factors, consistent with principles of epidemiological analysis and public health evaluation.